| Literature DB >> 21497643 |
Quan-Xin Wang1, Sai-Fei Li, Feng Zhao, Huan-Qin Dai, Li Bao, Rong Ding, Hao Gao, Li-Xin Zhang, Hua-An Wen, Hong-Wei Liu.
Abstract
A new oxysporidinone analogue (1) and a new 3-hydroxyl-2-piperidinone derivative (2), along with the known compounds (-)-4,6'-anhydrooxysporidinone (3), (+)-fusarinolic acid (4), gibepyrone D (5), beauvercin (6),cerevisterol (7), fusaruside (8), and (2S,2'R,3R,3'E,4E,8E)-1-O-D-glucopyranosyl-2-N-(2'-hydroxy-3'-octadecenoyl)-3-hydroxy-9-methyl-4,8-sphingadienine (9) were isolated from Fusarium oxysporum. Compounds 1-9 were evaluated for cytotoxicity using the MTT method against cancer cell lines, PC-3, PANC-1, and A549. Beauvericin showed cytotoxicity against PC-3, PANC-1, and A549 with IC(50) value of 49.5 ± 3.8, 47.2 ± 2.9, and 10.4 ± 1.6μM, respectively. Beauvericin also exhibited anti-bacterial activity towards methicillin-resistant Staphylococcus aureus (MIC=3.125 μg/mL) and Bacillus subtilis (MIC=3.125 μg/mL).Entities:
Mesh:
Substances:
Year: 2011 PMID: 21497643 DOI: 10.1016/j.fitote.2011.04.002
Source DB: PubMed Journal: Fitoterapia ISSN: 0367-326X Impact factor: 2.882